METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE

Similar documents
Development and validation of stability indicating RP-LC method for estimation of calcium dobesilate in pharmaceutical formulations

Development and Validation for Simultaneous Estimation of Sitagliptin and Metformin in Pharmaceutical Dosage Form using RP-HPLC Method

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR ESTIMATION OF LACOSAMIDE IN BULK AND ITS PHARMACEUTICAL FORMULATION

Simultaneous Estimation of Gemcitabine Hydrochloride and Capecitabine Hydrochloride in Combined Tablet Dosage Form by RP-HPLC Method

Pelagia Research Library

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

A New Stability-Indicating and Validated RP-HPLC Method for the Estimation of Liraglutide in Bulk and Pharmaceutical Dosage Forms

Pelagia Research Library

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

Journal of Chemical and Pharmaceutical Research, 2013, 5(1): Research Article

RP-HPLC Method Development and Validation of Abacavir Sulphate in Bulk and Tablet Dosage Form

International Journal of Pharma and Bio Sciences DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF STRONTIUM RANELATE IN SACHET

Method Development and Validation for the Estimation of Saroglitazar in Bulk and Pharmaceutical Dosage Form by RP-HPLC

VALIDATED RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DEXAMETHASONE AND GRANISETRON IN COMBINED DOSAGE FORMS

Journal of Chemical and Pharmaceutical Research, 2017, 9(9): Research Article

Journal of Chemical and Pharmaceutical Research

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

A stability indicating RP-HPLC method for simultaneous estimation of darunavir and cobicistat in bulk and tablet dosage form

Development and validation of RP-HPLC method for simultaneous estimation of gliclazide and metformin in pure and tablet dosage form

Simultaneous estimation of Metformin HCl and Sitagliptin in drug substance and drug products by RP-HPLC method

CHAPTER 2 SIMULTANEOUS DETRMINATION OF ANASTROZOLE AND TEMOZOLOMIDE TEMOZOLOMIDE CAPSULES 20 MG AND ANASTROZOLE TABLETS 1 MG

ANALYTICAL TECHNIQUES FOR THE QUALITY OF ANTI- AIDS DRUGS

Isocratic Reversed Phase Liquid Chromatographic Method Validation for the Determination of Cilostazol in Pure and Formulations

Development and validation of related substances method for Varenicline and its impurities

Hyderabad, India. Department of Pharmaceutical Chemistry, Glocal University, Saharanpur, India.

ISSN (Print)

International Journal of Pharma and Bio Sciences

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS TOLBUTAMIDE IN PURE AND PHARMACEUTICAL FORMULATIONS

New RP-HPLC Method for the Determination of Fludarabine in Pharmaceutical Dosage Forms

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Scholars Research Library

DEVELOPMENT AND VALIDATION OF NEW HPLC METHOD FOR THE ESTIMATION OF PALIPERIDONE IN PHARMACEUTICAL DOSAGE FORMS

Volume 2 (6), 2014, Page CODEN (USA)-IJPRUR, e-issn: International Journal of Pharma Research and Health Sciences

36 J App Pharm Vol. 6; Issue 1: 36-42; January, 2014 Rao et al., 2014

SIMULTANEOUS ESTIMATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE IN TABLETS BY RP-HPLC METHOD

A simple validated RP-HPLC method for quantification of sumatriptan succinate in bulk and pharmaceutical dosage form

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Corresponding Author:

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

Available online at Scholars Research Library

Estimation of Emtricitabine in Tablet Dosage Form by RP-HPLC

AMERICAN JOURNAL OF BIOLOGICAL AND PHARMACEUTICAL RESEARCH

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ETORICOXIB AND THIOCOLCHICOSIDE IN PHARMACEUTICAL DOSAGE FORMS

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF TRAMADOL IN PURE AND PHARMACEUTICAL FORMULATIONS

Pankti M. Shah et al, Asian Journal of Pharmaceutical Technology & Innovation, 04 (17); 2016; 07-16

Development and Validation of a Simultaneous HPLC Method for Quantification of Amlodipine Besylate and Metoprolol Tartrate in Tablets

Stability indicating RP-HPLC method development and validation of Etizolam and Propranolol hydrochloride in pharmaceutical dosage form

S. G. Talele, D. V. Derle. Department of Pharmaceutics, N.D.M.V.P. College of Pharmacy, Nashik, Maharashtra, India

Development of a Validated RP-HPLC Method for the Analysis of Citicoline Sodium in Pharmaceutical Dosage Form using Internal Standard Method

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF BACLOFEN IN BULK AND PHARMACEUTICAL DOSAGE FORMS

J Pharm Sci Bioscientific Res (4): ISSN NO

Validation of UV Spectrophotometric and HPLC Methods for Quantitative determination of Iloperidone in Pharmaceutical Dosage Form

Available online Research Article

Development and Validation of RP-HPLC Method for the Estimation of Gemigliptin

NOVEL RP-HPLC METHOD. B.Lakshmi et a. concentration range KEY INTRODUCTION. Diltiazem is used to. . It works by of contractionn of the. (dilate).

Journal of Chemical and Pharmaceutical Research, 2014, 6(7): Research Article

Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Haloperidol and Trihexyphenidyl in API and Combined Tablet Dosage Form

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

Estimation of zolmitriptan by a new RP-HPLC method

Stress Degradation Studies And Validation Method For Quantification Of Aprepitent In Formulations By Using RP-HPLC

Method Development and Validation for Simultaneous Estimation of Atorvastatin and Ezetimibe in Pharmaceutical Dosage Form by HPLC

Validation of Developed Analytical Method for Balofloxacin Floating Tablets by Reverse Phase High Performance Liquid Chromatography

Sujatha and Pavani et.al. Indian Journal of Research in Pharmacy and Biotechnology ISSN: (Print) ISSN: (Online)

Journal of Pharmacreations

Rao and Gowrisankar: Stability-indicating RP-HPLC Method for Pseudoephedrine, Ambroxol and Desloratadine

ASSAY AND IMPURITY METHOD FOR DURACOR TABLETS BY HPLC

SIMULTANEOUS QUANTIFICATION OF TELMISARTAN AND METOPROLOL SUCCINATE IN TABLETS BY LIQUID CHROMATOGRAPHY

International Journal of Medicine and Pharmaceutical Research. International Journal of Medicine and Pharmaceutical Research

Scholars Research Library. Der Pharmacia Lettre, 2015, 7 (5):44-49 (

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR CILOSTAZOL IN TABLET DOSAGE FORM

(ACE) inhibitor class that is primarily used in cardiovascular. conditions. Lisinopril was introduced into therapy in the early

International Journal of Farmacia

Tentu Nageswara Rao et al. / Int. Res J Pharm. App Sci., 2012; 2(4): 35-40

Journal of Chemical and Pharmaceutical Research

Journal of Chemical and Pharmaceutical Research, 2018, 10(3): Research Article

Analytical Method Development and Validation for the Estimation of Imatinib Mesylate and its Impurity in Pharmaceutical Formulation by RP-HPLC

Analytical Method Development and Validation for the Estimation of Guaifenesin and Dextromethorphan by RP-HPLC

Available online Research Article

A HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ASSAY FOR LERCANIDIPINE HYDROCHLORIDE

International Journal of Drug Research and Technology

Airo International Research Journal ISSN : Volume : 7 October 2015

Sanjog Ramdharane 1, Dr. Vinay Gaitonde 2

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ANALYISIS OF RIFAXIMIN IN PHARMACEUTICAL DOSAGE FORMS

Int. J. Pharm. Sci. Rev. Res., 24(2), Jan Feb 2014; nᵒ 18,

Research Article Simultaneous Estimation of DL-Methionine and Pyridoxine Hydrochloride in Tablet Dosage Form by RP-HPLC

A Reverse Phase HPLC Method Development and Validation for the Determination of Paliperidone in Pure and Dosage Forms

Scholars Research Library. Der Pharmacia Lettre, 2016, 8 (6): (

Dhull Rohit, Kumar Sanjay, Jalwal Pawan Department of Chemistry, OPJS Churu, Rajasthan, India

Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms

Ankit et al Journal of Drug Delivery & Therapeutics; 2013, 3(2), Available online at RESEARCH ARTICLE

Journal of Global Trends in Pharmaceutical Sciences

RP-HPLC Method for the Simultaneous Estimation of Sitagliptin Phosphate and Metformin Hydrochloride in Combined Tablet Dosage Forms

IAJPS 2018, 05 (01), J. Amutha Iswarya Devi et al ISSN Available online at:

ESTIMATION OF RELATED SUBSTANCES OF FEBUXOSTAT IN BULK & 40/80/120mg TABLETS BY RP-HPLC

Int. J. Pharm. Sci. Rev. Res., 30(1), January February 2015; Article No. 32, Pages:

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Estimation of Zanamivir Drug present in Tablets using RP-HPLC Method

Transcription:

WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES Ramalakshmi et al. SJIF Impact Factor 6.647 Volume 7, Issue 2, 1010-1018 Research Article ISSN 2278 4357 METHOD DEVELOPMENT AND VALIDATION BY RP-HPLC FOR ESTIMATION OF ZOLPIDEM TARTARATE N. Ramalakshmi 1 *, C. N. Nalini 1, S. Sivaguru 1, A. Teja 1 and S. Arun Kumar 2 1 Department of Pharmaceutical Analysis, C. L. Baid Metha College of Pharmacy, Jyothi Nagar, Old Mahabalipuram Road, Thoraipakkam, Chennai 600097. 2 Gulf medical University, Ajman, UAE. Article Received on 29 November 2017, Revised on 19 Dec. 2017, Accepted on 09 Jan. 2018 DOI: 10.20959/wjpps20182-10905 *Corresponding Author Dr. N. Ramalakshmi Department of Pharmaceutical Analysis, C. L. Baid Metha College of Pharmacy, Jyothi Nagar, Old Mahabalipuram Road, Thoraipakkam, Chennai 600097. analysis. ABSTRACT The objective is to develop and validate a new simple, rapid and sensitive isocratic RP-HPLC method for the determination of Zolpidem tartarate. The method employs Waters Alliance HPLC system on Novapak C18 (3.9 x 150 mm, 4.0 m) column. Best chromatographic separation was achieved by using buffer, Acetonitrile and methanol (59:18:23) as mobile phase with a flow rate of 1.5ml/min and isocratic elution with a total run time of 10 minutes. Detection of the compound was carried out at 254nm. The retention time of Zolpidem tartarate was found to be 6.095. The linearity studies ranges from at the concentration range of 50-150 µg/ml and this method was validated for accuracy, precision, linearity, ruggedness and robustness as per ICH guidelines. The present newly developed method was found to be accurate, precise and can be useful for routine Quality control KEYWORDS: Zolpidem tartarate, RP-HPLC, ICH, Analytical method validation. INTRODUCTION Zolpidem tartarate is a hypnotic drug, chemically N, N, 6-Trimethyl-2-p-tolylimidazo [1,2] pyridine-3-acetamide L-(+)-Tartarate. [1] It interacts with a GABA-BZ receptor complex and shares some of the pharmacological properties of the benzodiazepines. Zolpidem tartarate tablets are available in tablet dosage form as 5mg, 10mg. Literature survey reveals good numbers of analytical methods are available for the estimation of this drugs. www.wjpps.com Vol 7, Issue 2, 2018. 1010

Various analytical methods including UV [2,3], HPTLC [4], and HPLC methods [5-7] are available for the estimation of Zolpidem tartarate in pharmaceutical dosage forms. We tried to develop a simple method for the estimation of Zolpidem tartarate by RP-HPLC in pharmaceutical dosage forms. The proposed method was optimized and validated as per the International Conference on Harmonization (ICH) guidelines. MATERIALS AND METHODS Instrumentation Waters alliance HPLC Novapak C18, 3.9 x 150 mm, 4.0 m particle size was used. The HPLC system is made up of 2695 separation module and 2998 photodiode array detector. The output was processed using Empower 2 software. Chemicals and solvents The working standard and samples of Zolpidem tartarate were obtained from PAR Formulations, Chennai, India. HPLC grade water, Acetonitrile (HPLC Grade), Orthophosphoric acid was obtained from Merck (India) Ltd, Mumbai, India. Chromatographic parameters The chromatographic separation was achieved by Novapak C18, 3.9 x 150 mm column. The mobile phase consists of Orthophosphoric acid buffer, Acetonitrile and Methanol in the ratio (59:18:23). The flow rate was maintained at 1.5 ml/min throughout the gradient program. The eluents were monitored at 254 nm. The column temperature was maintained at 30 o C. the injection volume was 20 µl. Mobile phase was also used as a diluent. Isocratic elution method was followed. Each sample was run for 10 min. Preparation of the Zolpidem tartarate Standard & Sample Solutions Preparation of Standard Stock Solution (100 µg/ml of Zolpidem Tartarate) Weigh accurately about 50 mg of Zolpidem tartarate WRS and transfer to a 50 ml volumetric flask. Add about 30 ml of diluent and sonicate to dissolve. Dilute to volume with diluent and mix well. Further, dilute 5 ml to 50 ml with diluent. Sample Preparation (For 10mg tablets) Weigh 20 tablets of Zolpidem Tartarate and transfer to a 200 ml volumetric flask. Add about 140 ml of diluent and sonicate for 10 minutes with intermittent shaking. Shake mechanically for 10 min. Dilute to volume with diluent and mix well. Centrifuge a portion of sample at www.wjpps.com Vol 7, Issue 2, 2018. 1011

3500RPM for 10 min. Dilute 5 ml of supernatant liquid to 50 ml with diluent. Filter through 0.45 µm nylon filter. Sample preparation (For 5mg tablets) Weigh 20 tablets of Zolpidem Tartarate and transfer to a 100 ml volumetric flask. Add about 70 ml of diluent and sonicate for 10 minutes with intermittent shaking. Shake mechanically for 10 min. Dilute to volume with diluent and mix well. Centrifuge a portion of sample at 3500RPM for 10 min. Dilute 5ml of supernatant liquid to 50 ml with diluent. Filter through 0.45 µm nylon filter. Injection of Standards and Samples into the Chromatographic system 20 µl of each standard and sample solution were injected into the chromatographic system and the area of Zolpidem tartarate peaks was measured. The assay results, expressed as % of the label claim, are in Table 1 (Fig. 1). This indicates that the amount of each drug in the product meets the requirements. RESULTS Method Development The objective of the proposed work was to develop and validate an HPLC method for the estimation of Zolpidem tartarate in bulk and pharmaceutical dosage forms. Initially, various mobile phase compositions were tried to elute title ingredients. Mobile phase and flow rate selection was based on peak parameters (height, capacity, theoretical plates, tailing or symmetry factor, run time, resolution). In RP-HPLC method development, the estimation was carried out by Water alliance HPLC auto sampler separation module with UV detector and column used was Novapak C18, 3.9 x 150 mm, i.e. column with 4μ particle size. Injection volume of 20 μl is injected and eluted with the mobile phase (ph 5.5), Acetonitrile and methanol with the ratio of (59:18:23), which is pumped at the flow rate of 1.5 ml/min. Detection was carried out at 254 nm. Quantification was done by calibration curve method with the above mentioned optimized chromatographic condition. System Suitability System Performance parameters of developed HPLC method were determined by injecting standard solutions. Parameters such as number of theoretical plates (N), tailing factor, www.wjpps.com Vol 7, Issue 2, 2018. 1012

resolution(r), retention time (RT) were determined. The results are shown in Table 2 (Fig. 3), it indicates good performance. Specificity Specificity was evaluated continually through the drug development process. The data is shown in Table 3. Blank/Placebo chromatogram did not show any disturbance peak at the retention times of Zolpidem tartarate. Linearity From the standard stock solutions, a suitably mixed standard solution was prepared to contain 50 to 150 % of the targeted level of the assay concentration of the standard drugs (containing internal standard). The solutions were examined by the assay procedure. The calibration curve was plotted using response factor (peak area ratio of the standard peak area and internal standard peak area) vs. concentration of the standard solution. From the calibration curve, the slope and intercept, correlation-coefficient was calculated. The calibration curves (Fig. 2) were constructed by plotting absorbance versus concentration and the regression equations were calculated. The results are shown in Table 4. The Correlation coefficient was found to be more than 0.99, which indicates that there was an excellent correlation between the peak area response and the concentration. Precision Precision may be considered at three levels: repeatability, intermediate precision and reproducibility. The precision of the analytical procedure is usually expressed as the variance, standard deviation or coefficient of variation of a series of measurements. The results obtained are tabulated as Table 5 (Fig. 4). The %RSD for the area of five standard injections results was found to be less than 2%. Accuracy The accuracy of an analytical procedure expresses the closeness of agreement between the value which is accepted either as a conventional true value or an accepted reference value and value found. The standard solution was injected with Accuracy 80%, 100% and 120% solutions. The amount found was calculated and amount added for Zolpidem tartarate were estimated. The individual recovery and mean recovery values were also calculated in Table 6. The % Recovery for each level was found to be between 98.0% and 102.0%. www.wjpps.com Vol 7, Issue 2, 2018. 1013

Robustness As part of the Robustness, deliberate change in the flow rate, ph was made to evaluate the impact on the method. The typical variations are given below: Variation in flow rate was by ± 0.2ml/min. Variation in ph in the Mobile phase varied from ±10%. The results are shown in Table 7. Ruggedness The assay was performed in different condition, different analyst, and different dates. The results are given in Table 8. Limit of Detection (LOD) Loss of Detection was calculated from the formula; LOD = 3.3σ /S Where, σ = standard deviation of the response, S = slope of calibration curve. Limit of Quantification (LOQ) Loss of Quantification was calculated from the formula; LOQ = 10σ /S Where, σ = standard deviation of the response, S = slope of calibration curve The results for Limit of Detection and Limit of Quantification are shown in the Table 9. TABLES Table 1: Assay of Zolpidem tartarate. Injection Zolpidem area Amount of Zolpidem in tablet % Recovery 1 4489226 9.998 99.98 2 4488776.98 9.997 99.97 3 4490573.02 10.001 100.01 Mean 449525.30 9.998 99.98 SD 934.72 0.00208 0.0208 % RSD 0.02 0.02 0.2 Table 2: System suitability. System Suitability Parameters of Theoretical Tailing Retention Zolpidem tartarate plates factor time Zolpidem 4955 1.073 6.095min Table 3: Interference of Blank and Placebo. Name Interference Retention time (min) Blank Nil Nil Placebo Nil 0.8 www.wjpps.com Vol 7, Issue 2, 2018. 1014

Table 4: Linearity of Zolpidem tartarate. Sl. No. Conc. of Zolpidem tartarate Peak area of µg/ml Zolpidem tartarate 1 50 2224389.035 2 60 2664373.18 3 80 3559912.21 4 100 4448778.07 5 150 6673612.07 Table 5: Precision of Zolpidem tartarate. Sl. No. Zolpidem tartarate Zolpidem tartarate Area Area System precision Method precision 1 4489226 4488776.98 2 4488776.98 4489226 3 4490573.02 4481143.75 4 4481143.75 4490573.02 5 4441701.79 4441701.79 AVG 4490573.02 4490573.02 STDEV 4480332.42 4480332.42 % RSD 0.43 0.43 Table 6: Accuracy and % Recovery of each analyte. Accuracy Level % Mean recovery % RSD 50 101.59 1.62 100 101.1 1.14 150 101.60 1.48 Table 7: Robustness Parameters of Zolpidem tartarate. Drug name Parameters Retention time (min) Area (mm 2 ) Flow rate 1 6.063 4319304.16 Flow rate 2 6.001 4242326.46 RSD 0.94 1.27 Temperature 1 6.001 4250879.53 ZOLPIDEM Temperature 2 5.990 4263709.14 TARTARATE RSD 0.13 0.21 Buffer 5.3 6.095 4275683.44 Buffer 5.7 6.096 4259432.59 RSD 0.01 0.27 www.wjpps.com Vol 7, Issue 2, 2018. 1015

Table 8: Ruggedness of Zolpidem tartarate. Number of injection Retention time (min) Area (mm 2 ) Injection 1 6.03 4323640.78 Injection 2 6.07 4314950.04 Injection 3 6.10 4341456.78 Injection 4 6.07 4397678.64 Injection 5 6.09 4397678.64 Mean 6.072 4355080.97 SD 0.026 40042.85 RSD 0. 44 0.92 Table 9: L.O.D. & L.O.Q. of Zolpidem tartarate. Name of drug Zolpidem 0.031 0.094 LOD LOQ Acceptance criteria Based on the standard deviation of the response and the slope Fig. 1: Assay of Zolpidem tartarate. Fig. 2: Linearity Curve for Zolpidem tartarate. www.wjpps.com Vol 7, Issue 2, 2018. 1016

Fig. 3: Typical Chromatogram of Zolpidem tartarate. Fig 4: Precision. DISCUSSION This system produced symmetric peak shape, good resolution and reasonable retention time of Zolpidem tartarate was found to be 6.695. The correlation coefficient(s) of Zolpidem tartarate was found to be 0.999 respectively for which indicates excellent correlation the peak area response Vs concentration of standard solutions. Precision of the developed methods was studied under system precision, method precision. The %RSD values for precision was found to be within the acceptable limit, which revealed that the developed method was precise. The developed method was found to be robust. The %RSD values for recovery percentage of Zolpidem tartarate was found to be within the acceptable criteria. The result indicates satisfactory accuracy of method for simultaneous estimation of the above mentioned drugs. CONCLUSION From all results it was concluded that the developed RP - HPLC method for the estimation of Zolpidem tartarate in dosage forms are accurate, precise, linear, robust, simple and rapid. www.wjpps.com Vol 7, Issue 2, 2018. 1017

Percentage recovery shows that the method is free from interference of excipients used in the formulation. ACKNOWLEDGEMENT 1. We would like to thank the management of C.L. Baid Metha College of Pharmacy, Chennai for their constant help & guidance and providing us a quality environment for completing our work. 2. We would like to thank PAR formulations, Chennai for providing us with the chemicals required for completing our work. REFERENCES 1. Sweetman S. Martindale: the complete drug reference. 36th ed. London: The Pharmaceutical Press; 2009. 2. The Merck Index, Merck & Co, Inc, 14 th edn. White house station, NJ, 2006. 3. Egginger G, Lindner W, Karh S, Stoschitzky K. Stereoselective HPLC bioanalysis of atenolol enantiomers in plasma: application to a comparative human pharmacokinetic study. Chirality. 1993; 5: 506-512. 4. http://bheem.hubpages.com/hub/hplc-detector-types. 5. Swarbrick JC, Boylan James. Suitable for preparative liquid chromatography on a much larger scale.encyclopedia of pharmaceutical technology, 1998; 1: 217-224. 6. Lindsay Sandy, HPLC by open learning., 1991; 30-45. 7. Lough WJ, Wainer IWW. HPLC fundamental principles and practices., 1991; 52-67. www.wjpps.com Vol 7, Issue 2, 2018. 1018